ATE20051T1 - Amidinderivate, verfahren zu ihrer herstellung und diese enthaltende antikomplement-mittel. - Google Patents

Amidinderivate, verfahren zu ihrer herstellung und diese enthaltende antikomplement-mittel.

Info

Publication number
ATE20051T1
ATE20051T1 AT81107274T AT81107274T ATE20051T1 AT E20051 T1 ATE20051 T1 AT E20051T1 AT 81107274 T AT81107274 T AT 81107274T AT 81107274 T AT81107274 T AT 81107274T AT E20051 T1 ATE20051 T1 AT E20051T1
Authority
AT
Austria
Prior art keywords
anticomplement
preparation
amidino
amide derivatives
agents containing
Prior art date
Application number
AT81107274T
Other languages
English (en)
Inventor
Setsuro Fujii
Toshiyuki Okutome
Toyoo Nakayama
Takashi Yaegashi
Masateru Kurumi
Original Assignee
Torii & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12826980A external-priority patent/JPS5753454A/ja
Priority claimed from JP6494281A external-priority patent/JPS57179146A/ja
Application filed by Torii & Co Ltd filed Critical Torii & Co Ltd
Application granted granted Critical
Publication of ATE20051T1 publication Critical patent/ATE20051T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
  • Power Steering Mechanism (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
AT81107274T 1980-09-16 1981-09-15 Amidinderivate, verfahren zu ihrer herstellung und diese enthaltende antikomplement-mittel. ATE20051T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12826980A JPS5753454A (en) 1980-09-16 1980-09-16 Guanidinobenzoate and anticomplementary agent
JP6494281A JPS57179146A (en) 1981-04-28 1981-04-28 Amidine compound
EP81107274A EP0048433B1 (de) 1980-09-16 1981-09-15 Amidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Antikomplement-Mittel

Publications (1)

Publication Number Publication Date
ATE20051T1 true ATE20051T1 (de) 1986-06-15

Family

ID=26406084

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81107274T ATE20051T1 (de) 1980-09-16 1981-09-15 Amidinderivate, verfahren zu ihrer herstellung und diese enthaltende antikomplement-mittel.

Country Status (17)

Country Link
US (2) US4454338A (de)
EP (1) EP0048433B1 (de)
KR (1) KR860000264B1 (de)
AT (1) ATE20051T1 (de)
AU (1) AU527371B2 (de)
CA (1) CA1177488A (de)
CS (1) CS228534B2 (de)
DD (1) DD201779A5 (de)
DE (1) DE3174717D1 (de)
DK (1) DK155003C (de)
ES (1) ES8206443A1 (de)
FI (1) FI73975C (de)
GB (1) GB2083818B (de)
HU (1) HU185956B (de)
NO (1) NO153568C (de)
PH (1) PH18109A (de)
SU (1) SU1176832A3 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine
DE3207033C2 (de) * 1981-02-27 1984-09-13 Torii & Co., Ltd., Tokyo Amidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
JPS57179147A (en) * 1981-04-28 1982-11-04 Torii Yakuhin Kk Amidine derivative
JPS59139357A (ja) * 1983-01-28 1984-08-10 Torii Yakuhin Kk アミジン誘導体
US4818273A (en) * 1983-11-14 1989-04-04 The Dow Chemical Company Substituted 1,2,4-triazolo[1,5-a]pyrimidine-2-sulfonamides, compositions containing them, and their utility as herbicides
US4563527A (en) * 1984-07-19 1986-01-07 Torii & Co., Ltd. Amidine compounds
JPS6133173A (ja) * 1984-07-25 1986-02-17 Torii Yakuhin Kk アミジン化合物
FR2568253B1 (fr) * 1984-07-26 1987-01-30 Torii Co Nouvelle amidine
GB2162171B (en) * 1984-07-26 1988-01-27 Torii & Co Ltd Amidine compounds
DE3427865A1 (de) * 1984-07-27 1986-02-06 Torii & Co., Tokio/Tokyo Amidinoverbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
US4709082A (en) * 1984-10-25 1987-11-24 Nissan Chemical Industries, Ltd. 2-phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof
US4873253A (en) * 1987-03-30 1989-10-10 Shosuke Okamoto Phenylalanine derivative and proteinase inhibitor
US4990537A (en) * 1988-07-11 1991-02-05 Banyu Pharmaceutical Co., Ltd. Anti influenza agent
ATE119523T1 (de) * 1989-12-28 1995-03-15 Snow Brand Milk Products Co Ltd Isochinolinderivate und ihre salze als proteasehemmer.
US5116985A (en) * 1989-12-28 1992-05-26 Snow Brand Milk Products Co., Ltd. Isoquinoline derivatives and salts thereof
US5238964A (en) * 1990-04-05 1993-08-24 Torii & Co., Ltd. Agent for treatment of cerebrovascular contraction
JPH078789B2 (ja) * 1990-04-05 1995-02-01 鳥居薬品株式会社 脳血管攣縮治療剤
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
EP0703216B1 (de) * 1994-09-20 1999-04-07 Ono Pharmaceutical Co., Ltd. Amidinophenol-Derivate als Protease-hemmende Verbindungen
ATE233240T1 (de) * 1994-12-02 2003-03-15 Yamanouchi Pharma Co Ltd Neues amidinonaphthylderivat oder dessen salz
ATE222583T1 (de) * 1995-01-05 2002-09-15 Torii Pharmaceutical Co Ltd Derivate substituierter amidinonaphthylester
EP0893437A4 (de) 1996-04-10 2000-12-27 Ono Pharmaceutical Co Tryptase-Inhibitor und Guanidino-Derivate
AU7808198A (en) 1997-06-03 1998-12-21 Biocryst Pharmaceuticals, Inc. Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
EP1030844A1 (de) * 1997-11-10 2000-08-30 Array Biopharma Inc. Verbindungen, die die aktivität von tryptase hemmen
US6066673A (en) 1998-03-12 2000-05-23 The Procter & Gamble Company Enzyme inhibitors
AU736951C (en) 1998-03-19 2003-02-20 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
EP1066272A4 (de) * 1998-03-27 2002-03-13 Biocryst Pharm Inc Neue verbindungen, die im komplement-, koagulat- und kallikrein-reaktionsweg nützlich sind und verfahren zu ihrer herstellung
WO1999055661A1 (en) * 1998-04-24 1999-11-04 Proteus Molecular Design Limited Aminomethyl-benzoic ester derivatives as tryptase inhibitors
US6362216B1 (en) 1998-10-27 2002-03-26 Array Biopharma Inc. Compounds which inhibit tryptase activity
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
US7982008B2 (en) 2002-11-27 2011-07-19 David Bar-Or Treatment of diseases and conditions mediated by increased phosphorylation
AU2004275821A1 (en) * 2003-09-25 2005-04-07 Dmi Biosciences Inc. Methods and products which utilize N-acyl-L-aspartic acid
ES2354223T3 (es) * 2005-05-17 2011-03-11 Santen Pharmaceutical Co., Ltd. Derivados de amidina para uso en la prevención o el tratamiento de glaucoma.
EP1884236B1 (de) * 2005-05-17 2011-03-02 Santen Pharmaceutical Co., Ltd. Ein aminderivat als wirkstoff enthaltender angiogeneseinhibitor
GB2445920A (en) * 2007-01-25 2008-07-30 Mucokinetica Ltd Amidino compounds for treatment of respiratory disease
EP2311810A4 (de) * 2008-07-11 2012-04-04 Ajinomoto Kk Amidderivate
EP2349241B1 (de) 2008-10-17 2019-06-19 Signature Therapeutics, Inc. Pharmazeutische zusammensetzungen mit abgeschwächter freisetzung phenolischer opioide
SG179026A1 (en) 2009-09-08 2012-04-27 Signature Therapeutics Inc Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
EP2560486B1 (de) 2010-04-21 2018-11-21 Signature Therapeutics, Inc. Zusammensetzungen aus enzymspaltbaren amphetamin-prodrugs und hemmern dafür
US20110262355A1 (en) 2010-04-21 2011-10-27 Jenkins Thomas E Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
US9238020B2 (en) 2010-04-21 2016-01-19 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
JP6042330B2 (ja) 2010-07-09 2016-12-14 ビーエイチヴィ ファーマ、インコーポレイテッド レモグリフロジンを含めた半減期が短い医薬品のための組合せ即時／遅延放出送達システム
US8497237B2 (en) 2011-01-11 2013-07-30 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable oxycodone prodrug
JP6016810B2 (ja) 2011-01-11 2016-10-26 シグネーチャー セラピューティクス, インク.Signature Therapeutics, Inc. 酵素切断可能なオキシコドンプロドラッグを含んでなる組成物
WO2012122420A2 (en) 2011-03-09 2012-09-13 Pharmacofore, Inc. Opioid prodrugs with heterocyclic linkers
AU2012225337B2 (en) 2011-03-09 2016-04-28 Signature Therapeutics, Inc. Active agent prodrugs with heterocyclic linkers
CA2848561C (en) 2011-09-15 2019-04-02 Astellas Pharma Inc. Guanidinobenzoic acid compound
CN103012214A (zh) * 2011-09-28 2013-04-03 南京长澳医药科技有限公司 一种萘莫司他盐酸盐及萘莫司他甲磺酸盐的制备方法
PT2975023T (pt) * 2013-03-13 2018-07-27 Takeda Pharmaceuticals Co Composto de éster de ácido guanidinobenzoico
CN103641749B (zh) * 2013-12-02 2016-02-10 山东永泰化工有限公司 一种甲磺酸萘莫司他的制备方法
US9428470B2 (en) 2014-02-13 2016-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
US9346776B2 (en) 2014-02-13 2016-05-24 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
CN110330447B (zh) * 2019-07-16 2022-04-15 北京赛升药业股份有限公司 一种甲磺酸萘莫司他中间体的制备方法及其应用
EP4094758A4 (de) * 2020-01-21 2024-02-21 Academy of Military Medical Sciences Verwendung von benzoatverbindungen zur behandlung von sars-cov-2-infektionen
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN111574409A (zh) * 2020-05-14 2020-08-25 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) 一种甲磺酸萘莫司他的重结晶工艺方法
CN113999145B (zh) * 2021-11-12 2023-02-03 开封明仁药业有限公司 一种甲磺酸萘莫司他的合成方法
CN118488831A (zh) 2021-12-23 2024-08-13 苏宾特罗有限公司 包含油酸的新抗病毒组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD89611A (de) *
DE1905813A1 (de) * 1968-07-04 1970-03-05 Akad Wissenschaften Ddr 3- oder 4-Guanidobenzoesaeurebenzyl- oder -phenylestern und deren Verwendung als Inhibitoren
GB1472700A (en) * 1974-11-01 1977-05-04 Ono Pharmaceutical Co Guanidinobehzoic acid derivatives and process for preparing the same
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine

Also Published As

Publication number Publication date
ES505460A0 (es) 1982-08-16
DD201779A5 (de) 1983-08-10
PH18109A (en) 1985-03-22
FI73975C (fi) 1987-12-10
HU185956B (en) 1985-04-28
DK155003B (da) 1989-01-23
DK155003C (da) 1989-05-29
FI73975B (fi) 1987-08-31
US4454338A (en) 1984-06-12
AU527371B2 (en) 1983-03-03
EP0048433B1 (de) 1986-05-28
CS228534B2 (en) 1984-05-14
EP0048433A3 (en) 1982-07-21
KR830007527A (ko) 1983-10-21
NO813138L (no) 1982-03-17
FI812876L (fi) 1982-03-17
CA1177488A (en) 1984-11-06
NO153568C (no) 1986-05-21
AU7506281A (en) 1982-03-25
DE3174717D1 (en) 1986-07-03
US4532255A (en) 1985-07-30
GB2083818B (en) 1984-05-10
NO153568B (no) 1986-01-06
KR860000264B1 (ko) 1986-03-22
DK410681A (da) 1982-03-17
SU1176832A3 (ru) 1985-08-30
ES8206443A1 (es) 1982-08-16
EP0048433A2 (de) 1982-03-31
GB2083818A (en) 1982-03-31

Similar Documents

Publication Publication Date Title
ATE20051T1 (de) Amidinderivate, verfahren zu ihrer herstellung und diese enthaltende antikomplement-mittel.
ATE58534T1 (de) 2-pyrimidinyl-l-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE38988T1 (de) Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
HU173950B (hu) Sposob poluchenija al'fa-al'fa-dvoezamehhennykh proizvodnykh uksusnojj kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
ES470296A1 (es) Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos
ES8102148A1 (es) Metodo de preparar 3-0-(beta-d-glucuronopiranosil)-sojasapo-genol b y similares
ES480113A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES8307249A1 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
WO1990003172A3 (en) Bile acids for treatment of viral infections
JPS549240A (en) New derivative of phenylglycolic acid, its preparation and analgesic and antiinflammatory agent contining it as effective component
JPS5395912A (en) New derivative of active acetic acid ulceratives
JPS5239622A (en) Process for preparation of methacrylic acid
JPS52136165A (en) Purification of pyrrolidine derivatives
JPS5233662A (en) Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof
ES8303344A1 (es) Procedimiento para la obtencion de esteres de fenoxipiridilmetilo.
JPS51125376A (en) Process for preparing urea clathrate compounds of ascorbic acid deriva tives
ES8504720A1 (es) Un procedimiento para la preparacion de esteres del acido carbonico
JPS5356662A (en) Thio lactams and process for preparation of the same
JPS5231061A (en) Preparation of n2- naphthalenesulfonylalginamides or acid addition sal ts thereof
JPS5271490A (en) Synthesis of 2-hydrocarbylidene-cephem detivatives
JPS53101373A (en) Imidazole-4(5)-carboxylic acid anilide derivatives
JPS5231093A (en) Preparation of 3- methylenecephalosporanic acid derivatives
JPS53101328A (en) Succinic acid anhydride derivatives and process for their preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time